PL3331517T3 - Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce - Google Patents

Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce

Info

Publication number
PL3331517T3
PL3331517T3 PL16750804T PL16750804T PL3331517T3 PL 3331517 T3 PL3331517 T3 PL 3331517T3 PL 16750804 T PL16750804 T PL 16750804T PL 16750804 T PL16750804 T PL 16750804T PL 3331517 T3 PL3331517 T3 PL 3331517T3
Authority
PL
Poland
Prior art keywords
hydroxycarbamide
perfusion
preventing retinal
retinal non
preventing
Prior art date
Application number
PL16750804T
Other languages
English (en)
Inventor
Yves Colin
Jean-François GIRMENS
Olivier Hermine
Emmanuel Heron
Michel Paques
Original Assignee
Centre Hospitalier National D'ophtalmologie Quinze-Vingts
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Centre National De La Recherche Scientifique (Cnrs)
Imagine Institut Des Maladies Génétiques Necker Enfants Malades
Assistance Publique - Hôpitaux De Paris
Université Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier National D'ophtalmologie Quinze-Vingts, Institut National De La Santé Et De La Recherche Médicale (Inserm), Centre National De La Recherche Scientifique (Cnrs), Imagine Institut Des Maladies Génétiques Necker Enfants Malades, Assistance Publique - Hôpitaux De Paris, Université Paris Descartes filed Critical Centre Hospitalier National D'ophtalmologie Quinze-Vingts
Publication of PL3331517T3 publication Critical patent/PL3331517T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16750804T 2015-08-06 2016-08-08 Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce PL3331517T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306277 2015-08-06
PCT/EP2016/068908 WO2017021560A1 (fr) 2015-08-06 2016-08-08 Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne
EP16750804.3A EP3331517B1 (fr) 2015-08-06 2016-08-08 Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne

Publications (1)

Publication Number Publication Date
PL3331517T3 true PL3331517T3 (pl) 2020-06-29

Family

ID=53836030

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16750804T PL3331517T3 (pl) 2015-08-06 2016-08-08 Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce

Country Status (6)

Country Link
US (1) US10617658B2 (pl)
EP (1) EP3331517B1 (pl)
ES (1) ES2770698T3 (pl)
PL (1) PL3331517T3 (pl)
PT (1) PT3331517T (pl)
WO (1) WO2017021560A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165095B1 (en) * 1999-03-02 2008-05-28 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
US6462071B1 (en) 2000-03-02 2002-10-08 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
US7008960B1 (en) * 1999-03-02 2006-03-07 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
WO2006004795A2 (en) * 2004-06-25 2006-01-12 The Johns Hopkins University Angiogenesis inhibitors
US20140171504A1 (en) * 2012-12-14 2014-06-19 Georgia Regents Research Institute, Inc. Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters

Also Published As

Publication number Publication date
US20180221313A1 (en) 2018-08-09
ES2770698T3 (es) 2020-07-02
EP3331517B1 (fr) 2019-11-06
WO2017021560A1 (fr) 2017-02-09
US10617658B2 (en) 2020-04-14
EP3331517A1 (fr) 2018-06-13
PT3331517T (pt) 2020-02-18

Similar Documents

Publication Publication Date Title
IL253945A0 (en) kdm1a inhibitors to treat the disease
HK1225968A1 (zh) 用於治療hbv感染的組合療法
SG11201706729SA (en) Derivatives of sobetirome
HK1258062A1 (zh) 給予惡拉戈利的方法
IL263050B (en) History of Subtirum
SG11201609652RA (en) Treatment of polybacterials infections
IL250883A0 (en) Therapeutic compounds as orexin-1 receptor inhibitors
HK1251166A1 (zh) 平滑肌肉瘤的靶向療法
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
HK1248139A1 (zh) Olig2活性的抑制
IL249502A0 (en) Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of protein-associated diseases
EP3265177C0 (en) FORMULATIONS OF HYDROPHILIC COMPOUNDS
ZA201800163B (en) New anti-malarial agents
PL3142641T3 (pl) Preparaty do leczenia nadczynności tarczycy
HK1246679A1 (zh) 絲蟲病的治療
EP3091985A4 (en) Treatment of migraines
GB201412010D0 (en) Treatment of hypertransaminasemia
HK1248551A1 (zh) 用於治療精神分裂症的伊潘立酮
PL3331517T3 (pl) Zastosowanie hydroksymocznika w celu zapobiegania brakowi perfuzji w siatkówce
PL3302463T3 (pl) Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
HUP1400518A2 (hu) Eljárás tofacitinib elõállítására
GB201512635D0 (en) Uses of therapeutic compounds
GB201607438D0 (en) New use of pemirolast
GB201607437D0 (en) New use of pemirolast
GB201504413D0 (en) Treatment of disease